JUSIL RICE: Open Payments
NPI 1134474588 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 11 payments from 8 companies in 2025. Trend: 2023 $313 · 2024 $211 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $111 |
| AstraZeneca Pharmaceuticals LP | 1 | $96 |
| Novo Nordisk Inc | 2 | $50 |
| Dexcom, Inc. | 2 | $32 |
| Abbott Laboratories | 1 | $24 |
| Corcept Therapeutics | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: NUCALA, FASENRA, Ozempic, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, Korlym, ACTHAR, CUVITRU.
Industry payments across FL — which companies pay providers there.
